University of Maryland's Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $6.0 million grant entitled, "Structure-Based Vaccine Design for Hepatitis C Virus," to develop a novel prophylactic vaccine to prevent hepatitis C viru